Possible Role of Transthyretin in the Biological Mechanism of the Regulatory Peptide Neuroprotection

Understanding how neuroprotective peptides work at the molecular level is essential for optimizing their clinical use. This study by Vyunova, Medvedeva, Andreeva, and colleagues investigated a potential new mechanism behind Semax's well-documented neuroprotective effects during ischemic stroke.

The researchers examined how Semax affects gene transcription profiles in rat brain tissue experiencing focal ischemia (reduced blood flow). They focused particularly on changes in transthyretin (Ttr) expression, a protein with known neuroprotective properties that transports thyroid hormones and helps clear amyloid beta from the brain.

The results revealed that Semax significantly altered transthyretin gene expression, with dramatic differences observed between untreated ischemic conditions and those treated with Semax. The magnitude of the Ttr expression change suggested this pathway may be a major mediator of Semax's protective effects during stroke.

This discovery adds an important piece to our understanding of how Semax protects the brain. Transthyretin has established roles in neuroprotection, amyloid clearance, and thyroid hormone transport — all processes critical for brain health. By identifying Ttr as a potential mediator of Semax's effects, this study suggests the peptide's benefits extend beyond simple neurotrophic factor activation to encompass broader neuroprotective mechanisms.